NCT00911170 2017-12-29PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation StudyAmgenPhase 3 Completed847 enrolled 21 charts
NCT02732327 2017-07-21Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With CancerForest LaboratoriesPhase 2 Terminated2 enrolled 2 charts
NCT01569087 2016-12-05Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast CancerBiocadPhase 2 Completed60 enrolled 17 charts
NCT02104830 2016-10-24Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer PatientsBiocadPhase 3 Completed135 enrolled 18 charts